2025 in review: Celebrating biotech breakthroughs and key milestones with our clients
Reflecting on 2025, the biotech industry considerably advanced in gene editing, oncology, and AI-driven drug discovery and saw increased M&A activity. We also witnessed a notable shift from oncology innovations […]